The International Conference on Harmonisation (ICH) has released the long-awaited ICH E6 (R3) final guidance.
View our webinar to understand the impact that these regulatory guidance changes have on you and your organization. We will discuss the key updates to support successful adoption and enable you to get ahead of the curve.
Watch the recording below to maintain continuous compliance in your clinical trials:
Speakers
Michelle Webb
Vice President, Avoca Quality Consortium, WCG
Karen Harvey
Senior Director, Avoca Quality Consortium, WCG
Successfully implement ICH E6 (R3) guidance updates with support through WCG’s Avoca Quality Consortium (AQC) membership and consulting solutions.
Leverage the AQC’s ICH E6 (R2)/(R3) Side-by-Side Comparison resource to support continuous quality compliance. Over 200 clinical research organizations collaborate as part of the AQC and benefit from access to 1,500+ industry tools, templates, and metrics for every stage of the clinical trial process.
Inquire about Avoca Quality Consortium membership benefits for your organization
To request information on membership benefits for your company, complete this form.